DSG2 and neoplasm: Modifications to Ad5, such as expressing an epithelial junction opener, enhance its anti-tumor effect by increasing its affinity to desmoglein 2 (DSG2), a protein over-expressed in epithelial cancers, thereby improving virus penetration [73,188].